Speculation is not evidence: antihypertensive therapy and COVID-19.
作者信息
de Simone Giovanni, Mancusi Costantino
机构信息
Hypertension Research Center, Department of Advanced Biomedical Sciences, Federico II University Hospital, Naples, Italy.
出版信息
Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(3):133-134. doi: 10.1093/ehjcvp/pvaa021.
Abstract
摘要
相似文献
1
Speculation is not evidence: antihypertensive therapy and COVID-19.
Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(3):133-134. doi: 10.1093/ehjcvp/pvaa021.
2
Antihypertensive drugs and risk of COVID-19?
Lancet Respir Med. 2020 May;8(5):e30-e31. doi: 10.1016/S2213-2600(20)30153-3. Epub 2020 Mar 26.
3
Antihypertensive drugs and risk of COVID-19?
Lancet Respir Med. 2020 May;8(5):e29. doi: 10.1016/S2213-2600(20)30156-9. Epub 2020 Mar 26.
4
Antihypertensive drugs and risk of COVID-19?
Lancet Respir Med. 2020 May;8(5):e28. doi: 10.1016/S2213-2600(20)30158-2. Epub 2020 Mar 26.
5
Antihypertensive drugs and risk of COVID-19? - Authors' reply.
Lancet Respir Med. 2020 May;8(5):e32-e33. doi: 10.1016/S2213-2600(20)30159-4. Epub 2020 Mar 26.
6
Switching antihypertensive therapy in times of COVID-19: why we should wait for the evidence.
Eur Heart J. 2020 May 14;41(19):1857. doi: 10.1093/eurheartj/ehaa335.
7
Could patients taking isotretinoin therapy be immune against SARS-CoV-2?
Dermatol Ther. 2020 Jul;33(4):e13573. doi: 10.1111/dth.13573. Epub 2020 May 29.
8
Antihypertensive treatment with ACEI/ARB of patients with COVID-19 complicated by hypertension.
Hypertens Res. 2020 Jun;43(6):588-590. doi: 10.1038/s41440-020-0433-1. Epub 2020 Mar 30.
9
Age but not sex may explain the negative effect of arterial hypertension and diabetes on COVID-19 prognosis.
J Infect. 2020 Oct;81(4):647-679. doi: 10.1016/j.jinf.2020.05.010. Epub 2020 May 11.
10
Angiotensin receptor blockers and COVID-19.
Pharmacol Res. 2020 Jun;156:104832. doi: 10.1016/j.phrs.2020.104832. Epub 2020 Apr 15.
引用本文的文献
1
Brief review: Cardiac complications and platelet activation in COVID-19 infection.
Afr J Thorac Crit Care Med. 2020 Sep 16;26(3). doi: 10.7196/AJTCCM.2020.v26i3.107. eCollection 2020.
2
Cardiac complications in community-acquired pneumonia and COVID-19.
Afr J Thorac Crit Care Med. 2020 May 14;26(2). doi: 10.7196/AJTCCM.2020.v26i2.077. eCollection 2020.
3
Increased risk of acute kidney injury in coronavirus disease patients with renin-angiotensin-aldosterone-system blockade use: a systematic review and meta-analysis.
Sci Rep. 2021 Jun 30;11(1):13588. doi: 10.1038/s41598-021-92323-8.
4
Renin-angiotensin system inhibition and risk of infection and mortality in COVID-19: a systematic review and meta-analysis.
Intern Med J. 2020 Dec;50(12):1468-1474. doi: 10.1111/imj.15002. Epub 2020 Nov 16.
5
Risk factors associated with disease aggravation among 126 hospitalized patients with COVID-19 in different places in China: A retrospective observational study.
Medicine (Baltimore). 2020 Nov 6;99(45):e22971. doi: 10.1097/MD.0000000000022971.
6
SARS-CoV-2 receptor networks in diabetic and COVID-19-associated kidney disease.
Kidney Int. 2020 Dec;98(6):1502-1518. doi: 10.1016/j.kint.2020.09.015. Epub 2020 Oct 8.
7
Can COVID 2019 induce a specific cardiovascular damage or it exacerbates pre-existing cardiovascular diseases?
Pathol Res Pract. 2020 Sep;216(9):153086. doi: 10.1016/j.prp.2020.153086. Epub 2020 Jun 26.
8
Very low reporting rate of connective tissue diseases among coronavirus disease 2019 (Covid-19) patients and the renin-angiotensin system - An overlooked association?
Eur J Intern Med. 2020 Oct;80:106-107. doi: 10.1016/j.ejim.2020.06.012. Epub 2020 Jun 12.
9
Related molecular mechanisms of COVID-19, hypertension, and diabetes.
Am J Physiol Endocrinol Metab. 2020 Jun 1;318(6):E881. doi: 10.1152/ajpendo.00164.2020.
10
Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence.
J Clin Med. 2020 May 11;9(5):1417. doi: 10.3390/jcm9051417.
本文引用的文献
1
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
2
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
Lancet Respir Med. 2020 Apr;8(4):e21. doi: 10.1016/S2213-2600(20)30116-8. Epub 2020 Mar 11.
3
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.
JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994.
4
Association Between Renin-Angiotensin System Blockade Discontinuation and All-Cause Mortality Among Persons With Low Estimated Glomerular Filtration Rate.
JAMA Intern Med. 2020 May 1;180(5):718-726. doi: 10.1001/jamainternmed.2020.0193.
5
Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target.
Intensive Care Med. 2020 Apr;46(4):586-590. doi: 10.1007/s00134-020-05985-9. Epub 2020 Mar 3.
6
Structure analysis of the receptor binding of 2019-nCoV.
Biochem Biophys Res Commun. 2020 Feb 17;525(1):135-40. doi: 10.1016/j.bbrc.2020.02.071.
7
Treating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola.
Ann Transl Med. 2016 Nov;4(21):421. doi: 10.21037/atm.2016.11.03.
8
Treating Ebola patients: a 'bottom up' approach using generic statins and angiotensin receptor blockers.
Int J Infect Dis. 2015 Jul;36:80-4. doi: 10.1016/j.ijid.2015.04.019.
9
Population attributable risks of hypertension and diabetes for cardiovascular disease and stroke in the northern Manhattan study.
J Am Heart Assoc. 2014 Sep 16;3(5):e001106. doi: 10.1161/JAHA.114.001106.
10
Angiotensin-(1-9) reverses experimental hypertension and cardiovascular damage by inhibition of the angiotensin converting enzyme/Ang II axis.
J Hypertens. 2014 Apr;32(4):771-83. doi: 10.1097/HJH.0000000000000094.
Zotero 插件